Arkolith/Insider Trading/GERN/Form 4

Feller Faye

EVP, Chief Medical OfficerGERON CORP (GERN) · full profile →Form 4 · filed Jun 12, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.3M
Net Open-Market Flow
-$1.3M
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 10, 2024Option exercise(M)155K$1.30$202K155K
Jun 10, 2024Sell(S)288K$4.63$1.3M0
Jun 10, 2024Option exercise(M)113K$1.06$119K113K
Jun 10, 2024Option exercise(M)20K$1.06$21K20K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 10, 2024Option exercise(M)155K—$00
Jun 10, 2024Option exercise(M)113K—$088K
Jun 10, 2024Option exercise(M)20K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-072420) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML